Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma

Abroad (travel likely)RecruitingPHASE1

Conditions

Oncolytic Virus · Diffuse Intrinsic Pontine Glioma · Adverse Drug Event

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sanbo Brain Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Contact: Study coordinator (Weihai Ning, Dr.) · sanboocean@163.com · +86 15961868172

Study leads

Hongwei Zhang, Prof.
Principal Investigator
Capital Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma

Oncolytic Virus · Diffuse Intrinsic Pontine Glioma · Adverse Drug Event

Abroad (travel likely)RecruitingPHASE1

Beijing, China

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

Neoplasms, Brain · Glioblastoma Multiforme · Glioblastoma of Cerebellum

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · St Louis, United States

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

Glioma

Abroad (travel likely)RecruitingPHASE1

Houston, United States